4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide

C149H209ClF16N10O7S — CID 161253234

IUPAC4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide
SMILESCC(C)(C)c1cc(F)cc(C(F)(F)F)c1.CC(C)(C)c1ccc(CN2CCOCC2)c(Cl)c1.CC(C)(C)c1ccc(F)c(C(=O)Cc2ccccc2)c1.CC(C)(C)c1ccc(F)c(C(=O)N2CCCC2)c1.CC(C)(C)c1cccc(NS(C)(=O)=O)c1.CC(C)N1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CC(C)c1cccc(C(C)C)c1.CC(C)c1ccccc1C(=O)NCCO.CF.CN1CCCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CN1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1
InChIInChI=1S/C19H29F3N2.C18H27F3N2.C18H19FO.C17H25F3N2.C15H22ClNO.C15H20FNO.C12H17NO2.C12H18.C11H12F4.C11H17NO2S.CH3F/c1-14(2)24-10-8-23(9-11-24)13-15-6-7-16(18(3,4)5)12-17(15)19(20,21)22;1-17(2,3)15-7-6-14(16(12-15)18(19,20)21)13-23-9-5-8-22(4)10-11-23;1-18(2,3)14-9-10-16(19)15(12-14)17(20)11-13-7-5-4-6-8-13;1-16(2,3)14-6-5-13(15(11-14)17(18,19)20)12-22-9-7-21(4)8-10-22;1-15(2,3)13-5-4-12(14(16)10-13)11-17-6-8-18-9-7-17;1-15(2,3)11-6-7-13(16)12(10-11)14(18)17-8-4-5-9-17;1-9(2)10-5-3-4-6-11(10)12(15)13-7-8-14;1-9(2)11-6-5-7-12(8-11)10(3)4;1-10(2,3)7-4-8(11(13,14)15)6-9(12)5-7;1-11(2,3)9-6-5-7-10(8-9)12-15(4,13)14;1-2/h6-7,12,14H,8-11,13H2,1-5H3;6-7,12H,5,8-11,13H2,1-4H3;4-10,12H,11H2,1-3H3;5-6,11H,7-10,12H2,1-4H3;4-5,10H,6-9,11H2,1-3H3;6-7,10H,4-5,8-9H2,1-3H3;3-6,9,14H,7-8H2,1-2H3,(H,13,15);5-10H,1-4H3;4-6H,1-3H3;5-8,12H,1-4H3;1H3
InChIKeyVBNZXGLSGWBXJW-UHFFFAOYSA-N
MW2623.86 g/mol
LogP36.35
Rot. Bonds21

About 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide

4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide (PubChem CID 161253234) has the molecular formula C149H209ClF16N10O7S and a molecular weight of 2623.86 g/mol. Its IUPAC name is 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide.

Molecular Properties

Compound Name4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide
PubChem CID161253234
Molecular FormulaC149H209ClF16N10O7S
Molecular Weight2623.86 g/mol
Exact Mass2621.55
IUPAC Name4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide
SMILESCC(C)(C)c1cc(F)cc(C(F)(F)F)c1.CC(C)(C)c1ccc(CN2CCOCC2)c(Cl)c1.CC(C)(C)c1ccc(F)c(C(=O)Cc2ccccc2)c1.CC(C)(C)c1ccc(F)c(C(=O)N2CCCC2)c1.CC(C)(C)c1cccc(NS(C)(=O)=O)c1.CC(C)N1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CC(C)c1cccc(C(C)C)c1.CC(C)c1ccccc1C(=O)NCCO.CF.CN1CCCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CN1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1
InChIInChI=1S/C19H29F3N2.C18H27F3N2.C18H19FO.C17H25F3N2.C15H22ClNO.C15H20FNO.C12H17NO2.C12H18.C11H12F4.C11H17NO2S.CH3F/c1-14(2)24-10-8-23(9-11-24)13-15-6-7-16(18(3,4)5)12-17(15)19(20,21)22;1-17(2,3)15-7-6-14(16(12-15)18(19,20)21)13-23-9-5-8-22(4)10-11-23;1-18(2,3)14-9-10-16(19)15(12-14)17(20)11-13-7-5-4-6-8-13;1-16(2,3)14-6-5-13(15(11-14)17(18,19)20)12-22-9-7-21(4)8-10-22;1-15(2,3)13-5-4-12(14(16)10-13)11-17-6-8-18-9-7-17;1-15(2,3)11-6-7-13(16)12(10-11)14(18)17-8-4-5-9-17;1-9(2)10-5-3-4-6-11(10)12(15)13-7-8-14;1-9(2)11-6-5-7-12(8-11)10(3)4;1-10(2,3)7-4-8(11(13,14)15)6-9(12)5-7;1-11(2,3)9-6-5-7-10(8-9)12-15(4,13)14;1-2/h6-7,12,14H,8-11,13H2,1-5H3;6-7,12H,5,8-11,13H2,1-4H3;4-10,12H,11H2,1-3H3;5-6,11H,7-10,12H2,1-4H3;4-5,10H,6-9,11H2,1-3H3;6-7,10H,4-5,8-9H2,1-3H3;3-6,9,14H,7-8H2,1-2H3,(H,13,15);5-10H,1-4H3;4-6H,1-3H3;5-8,12H,1-4H3;1H3
InChIKeyVBNZXGLSGWBXJW-UHFFFAOYSA-N
XLogP36.35
TPSA164.79 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds21
Heavy Atoms184
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002623.86
LogP ≤ 536.35
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Analyze 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-2-propan-2-yloxybenzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide
CID 159136192
4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide
CID 159549866

Frequently Asked Questions

What is the IUPAC name of 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide?
The IUPAC name of 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide (CID 161253234) is 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide.
What is the SMILES notation for 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide?
The canonical SMILES for 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide is CC(C)(C)c1cc(F)cc(C(F)(F)F)c1.CC(C)(C)c1ccc(CN2CCOCC2)c(Cl)c1.CC(C)(C)c1ccc(F)c(C(=O)Cc2ccccc2)c1.CC(C)(C)c1ccc(F)c(C(=O)N2CCCC2)c1.CC(C)(C)c1cccc(NS(C)(=O)=O)c1.CC(C)N1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CC(C)c1cccc(C(C)C)c1.CC(C)c1ccccc1C(=O)NCCO.CF.CN1CCCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CN1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.
What is the InChIKey of 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide?
The InChIKey is VBNZXGLSGWBXJW-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H29F3N2.C18H27F3N2.C18H19FO.C17H25F3N2.C15H22ClNO.C15H20FNO.C12H17NO2.C12H18.C11H12F4.C11H17NO2S.CH3F/c1-14(2)24-10-8-23(9-11-24)13-15-6-7-16(18(3,4)5)12-17(15)19(20,21)22;1-17(2,3)15-7-6-14(16(12-15)18(19,20)21)13-23-9-5-8-22(4)10-11-23;1-18(2,3)14-9-10-16(19)15(12-14)17(20)11-13-7-5-4-6-8-13;1-16(2,3)14-6-5-13(15(11-14)17(18,19)20)12-22-9-7-21(4)8-10-22;1-15(2,3)13-5-4-12(14(16)10-13)11-17-6-8-18-9-7-17;1-15(2,3)11-6-7-13(16)12(10-11)14(18)17-8-4-5-9-17;1-9(2)10-5-3-4-6-11(10)12(15)13-7-8-14;1-9(2)11-6-5-7-12(8-11)10(3)4;1-10(2,3)7-4-8(11(13,14)15)6-9(12)5-7;1-11(2,3)9-6-5-7-10(8-9)12-15(4,13)14;1-2/h6-7,12,14H,8-11,13H2,1-5H3;6-7,12H,5,8-11,13H2,1-4H3;4-10,12H,11H2,1-3H3;5-6,11H,7-10,12H2,1-4H3;4-5,10H,6-9,11H2,1-3H3;6-7,10H,4-5,8-9H2,1-3H3;3-6,9,14H,7-8H2,1-2H3,(H,13,15);5-10H,1-4H3;4-6H,1-3H3;5-8,12H,1-4H3;1H3.
What are the key properties of 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide?
4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide has a molecular weight of 2623.86 g/mol, XLogP of 36.35, 21 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-(5-tert-butyl-2-fluorophenyl)-2-phenylethanone;(5-tert-butyl-2-fluorophenyl)-pyrrolidin-1-ylmethanone;1-tert-butyl-3-fluoro-5-(trifluoromethyl)benzene;N-(3-tert-butylphenyl)methanesulfonamide;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;1,3-di(propan-2-yl)benzene;fluoromethane;N-(2-hydroxyethyl)-2-propan-2-ylbenzamide is sourced from PubChem (CID 161253234), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).